Cargando…

p53/PCDH17/Beclin-1 Proteins as Prognostic Predictors for Urinary Bladder Cancer

Purpose: To determine whether p53, PCDH17, Beclin-1 expression is associated with clinicopathological characteristics of bladder cancer. Materials and Methods: 75 patients with non-muscle-invasive and muscle-invasive bladder cancer were included. Immunohistochemical staining for p53, PCDH17 and Becl...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Liuxi, Liu, Ying, Zhang, Qi, Zhang, Mingming, Han, Xuemeng, Li, Qiujie, Xie, Tian, Wu, Qibiao, Sui, Xinbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856748/
https://www.ncbi.nlm.nih.gov/pubmed/31772653
http://dx.doi.org/10.7150/jca.37335
_version_ 1783470635956043776
author Chen, Liuxi
Liu, Ying
Zhang, Qi
Zhang, Mingming
Han, Xuemeng
Li, Qiujie
Xie, Tian
Wu, Qibiao
Sui, Xinbing
author_facet Chen, Liuxi
Liu, Ying
Zhang, Qi
Zhang, Mingming
Han, Xuemeng
Li, Qiujie
Xie, Tian
Wu, Qibiao
Sui, Xinbing
author_sort Chen, Liuxi
collection PubMed
description Purpose: To determine whether p53, PCDH17, Beclin-1 expression is associated with clinicopathological characteristics of bladder cancer. Materials and Methods: 75 patients with non-muscle-invasive and muscle-invasive bladder cancer were included. Immunohistochemical staining for p53, PCDH17 and Beclin-1 were carried out on the same paraffin-embedded blocks serial sections of these patients who underwent surgery between 2010 and 2015. In addition, p53 gene mutations in these tumors were screened by DNA sequencing. Results: Forty-nine (66.7%) of 75 tumors had p53 gene mutations detected by DNA sequencing method. Of these tumors, 43 (86.0%) exhibited p53 high expression. Furthermore, p53 mutation and low expression of PCDH17 were significantly associated with muscle-invasive bladder cancer. Beclin-1 was also strongly associated with T stage. The p53 mutation, the expression of p53 and PCDH17 were significantly associated with survival from bladder cancer. In addition, patients with p53 high-expression or p53 mutation, PCDH17 low-expression and Beclin-1 low-expression significantly had a poor prognosis. Conclusions: Use of a DNA sequencing method to detect p53 gene mutations was consistent with an immunohistochemical method to detect p53 alterations. In conjunction with levels of p53/PCDH17/Beclin-1, p53 and PCDH17 were independently associated with prognosis; Beclin-1 only had a tendency towards overall survival. p53/PCDH17/Beclin-1 phenotype seems to play a more important role than p53 expression in bladder cancer outcome. It is also identified that p53/PCDH17, p53/Beclin-1 or PCDH17/Beclin-1 all have a cooperative and synergistic effect, which may provide us the potential biomarker for bladder cancer patients.
format Online
Article
Text
id pubmed-6856748
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-68567482019-11-26 p53/PCDH17/Beclin-1 Proteins as Prognostic Predictors for Urinary Bladder Cancer Chen, Liuxi Liu, Ying Zhang, Qi Zhang, Mingming Han, Xuemeng Li, Qiujie Xie, Tian Wu, Qibiao Sui, Xinbing J Cancer Research Paper Purpose: To determine whether p53, PCDH17, Beclin-1 expression is associated with clinicopathological characteristics of bladder cancer. Materials and Methods: 75 patients with non-muscle-invasive and muscle-invasive bladder cancer were included. Immunohistochemical staining for p53, PCDH17 and Beclin-1 were carried out on the same paraffin-embedded blocks serial sections of these patients who underwent surgery between 2010 and 2015. In addition, p53 gene mutations in these tumors were screened by DNA sequencing. Results: Forty-nine (66.7%) of 75 tumors had p53 gene mutations detected by DNA sequencing method. Of these tumors, 43 (86.0%) exhibited p53 high expression. Furthermore, p53 mutation and low expression of PCDH17 were significantly associated with muscle-invasive bladder cancer. Beclin-1 was also strongly associated with T stage. The p53 mutation, the expression of p53 and PCDH17 were significantly associated with survival from bladder cancer. In addition, patients with p53 high-expression or p53 mutation, PCDH17 low-expression and Beclin-1 low-expression significantly had a poor prognosis. Conclusions: Use of a DNA sequencing method to detect p53 gene mutations was consistent with an immunohistochemical method to detect p53 alterations. In conjunction with levels of p53/PCDH17/Beclin-1, p53 and PCDH17 were independently associated with prognosis; Beclin-1 only had a tendency towards overall survival. p53/PCDH17/Beclin-1 phenotype seems to play a more important role than p53 expression in bladder cancer outcome. It is also identified that p53/PCDH17, p53/Beclin-1 or PCDH17/Beclin-1 all have a cooperative and synergistic effect, which may provide us the potential biomarker for bladder cancer patients. Ivyspring International Publisher 2019-10-15 /pmc/articles/PMC6856748/ /pubmed/31772653 http://dx.doi.org/10.7150/jca.37335 Text en © The author(s) This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Chen, Liuxi
Liu, Ying
Zhang, Qi
Zhang, Mingming
Han, Xuemeng
Li, Qiujie
Xie, Tian
Wu, Qibiao
Sui, Xinbing
p53/PCDH17/Beclin-1 Proteins as Prognostic Predictors for Urinary Bladder Cancer
title p53/PCDH17/Beclin-1 Proteins as Prognostic Predictors for Urinary Bladder Cancer
title_full p53/PCDH17/Beclin-1 Proteins as Prognostic Predictors for Urinary Bladder Cancer
title_fullStr p53/PCDH17/Beclin-1 Proteins as Prognostic Predictors for Urinary Bladder Cancer
title_full_unstemmed p53/PCDH17/Beclin-1 Proteins as Prognostic Predictors for Urinary Bladder Cancer
title_short p53/PCDH17/Beclin-1 Proteins as Prognostic Predictors for Urinary Bladder Cancer
title_sort p53/pcdh17/beclin-1 proteins as prognostic predictors for urinary bladder cancer
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856748/
https://www.ncbi.nlm.nih.gov/pubmed/31772653
http://dx.doi.org/10.7150/jca.37335
work_keys_str_mv AT chenliuxi p53pcdh17beclin1proteinsasprognosticpredictorsforurinarybladdercancer
AT liuying p53pcdh17beclin1proteinsasprognosticpredictorsforurinarybladdercancer
AT zhangqi p53pcdh17beclin1proteinsasprognosticpredictorsforurinarybladdercancer
AT zhangmingming p53pcdh17beclin1proteinsasprognosticpredictorsforurinarybladdercancer
AT hanxuemeng p53pcdh17beclin1proteinsasprognosticpredictorsforurinarybladdercancer
AT liqiujie p53pcdh17beclin1proteinsasprognosticpredictorsforurinarybladdercancer
AT xietian p53pcdh17beclin1proteinsasprognosticpredictorsforurinarybladdercancer
AT wuqibiao p53pcdh17beclin1proteinsasprognosticpredictorsforurinarybladdercancer
AT suixinbing p53pcdh17beclin1proteinsasprognosticpredictorsforurinarybladdercancer